Showing results (61-70 of 308) with videos related to
Sort By:
Pageof 31
International Journal of Cardiology|June 4, 2013
Refuting the ticagrelor-aspirin black box warning: and proposing a ticagrelor early-PCI black box warningJames J DiNicolantonio, Victor L Serebruany, Ales TomekCardiology|February 1, 2007
Combination antiplatelet therapy with aspirin and clopidogrel: the role of antecedent and concomitant doses of aspirin. An analysis of 711 patientsVictor L Serebruany, Alex I Malinin, Dan AtarExpert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Cost-effectiveness of antiplatelet therapy for secondary stroke preventionDarya Malinina, Carla Zema, Stephen Sander, et al.TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Erratum to: "Comparison of ACUITY, CRUSADE, and GRACE Risk Scales for Predicting Clinical Outcomes in Patients Treated with Dual-Antiplatelet Therapy"Sun Young Choi, Moo Hyun Kim, Victor SerebruanyTH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Comparison of ACUITY, CRUSADE, and GRACE Risk Scales for Predicting Clinical Outcomes in Patients Treated with Dual-Antiplatelet TherapySun Young Choi, Moo Hyun Kim, Victor SerebruanyJournal of Thrombosis and Thrombolysis|January 1, 1995
Regional and Systemic Platelet Function Is Altered by Myocardial Ischemia-ReperfusionGurbel, Serebruany, Komjathy, et al.Cerebrovascular Diseases (Basel, Switzerland)|July 24, 2008
Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic strokeVadim Karepov, Galina Tolpina, Wiktor Kuliczkowski, et al.American Journal of Therapeutics|March 23, 2010
The in vitro effects of Xancor, a synthetic astaxanthine derivative, on hemostatic biomarkers in aspirin-naïve and aspirin-treated subjects with multiple risk factors for vascular diseaseVictor Serebruany, Alex Malinin, Thomas Goodin, et al.Expert Review of Cardiovascular Therapy|April 20, 2010
Aptamers: the emerging class of future anticoagulation for vascular diseaseWiktor Kuliczkowski, James Floyd, Alex Malinin, et al.The American Journal of Cardiology|July 20, 2015
Survival After Solid Cancers in Antithrombotic TrialsVictor L Serebruany, Ales Tomek, Moo Hyun KimPageof 31